Private Market View

Emalex Biosciences

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$285.0M
Last round
Early Stage VC
Oct 2022
Investors — not yet on record

No investors in Emalex Biosciences are on record yet. Backers surface from round announcements, filings, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·Watchlist + deal alerts for Emalex Biosciences
Create free account
No card required